Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy. (2022)
Attributed to:
Understanding the Properdin Paradox using C3 D1115N (gain-of-function) knock-in mice
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers14174288
PubMed Identifier: 36077823
Publication URI: http://europepmc.org/abstract/MED/36077823
Type: Journal Article/Review
Volume: 14
Parent Publication: Cancers
Issue: 17
ISSN: 2072-6694